Business · 14/02/2002Updated: 10/17/2026 · 1 min read
FDA Approves Supplemental New Animal Drug Application for Florfenicol Injectable Solution
Summary
The US Food and Drug Administration (FDA) has amended animal drug regulations to reflect approval of a supplemental new animal drug application filed by Schering-Plough Animal Health Corp., which allows for a change in the pathogen genus on labeling of florfenicol injectable solution.